Bone marrow graft in man after conditioning by antilymphocytic serum. - Wikidata - awgldk - TriplyDB

Bone marrow graft in man after conditioning by antilymphocytic serum.

Bone marrow graft in man after conditioning by antilymphocytic serum.

http://www.wikidata.org/entity/Q50417610

about

Clonal evolution of aplastic anaemia to myelodysplasia/acute myeloid leukaemia and paroxysmal nocturnal haemoglobinuria.Th17 immune responses contribute to the pathophysiology of aplastic anemia.Treatment of severe aplastic anaemia with antilymphocyte globulin or bone-marrow transplantation High-dose cyclophosphamide without stem cell rescue in 207 patients with aplastic anemia and other autoimmune diseases Severe fatigue: could it be aplastic anemia?Biology of BM failure syndromes: role of microenvironment and niches.Long-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioning Immune suppression therapy in aplastic anemia: influencing factors on response and survival.Limited heterogeneity of T cell receptor BV usage in aplastic anemia.Pharmacologic prophylaxis regimens for acute graft-versus-host disease: past, present and future.Horse versus rabbit antithymocyte globulin in acquired aplastic anemia Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.Hematopoietic stem cell transplantation for acquired aplastic anemia.Hematopoietic and immunologic tissue grafting. Current concepts and indications in pediatric patients.Highly skewed T-cell receptor V-beta chain repertoire in the bone marrow is associated with response to immunosuppressive drug therapy in children with very severe aplastic anemia.Antithymocyte immunoglobulin in severe aplastic anemia and bone marrow transplantation.The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967)Improved survival in severe acquired aplastic anemia of childhood.Acquired Aplasia of the Bone Marrow.Administration of anti-thymocyte globulin: a comparison of two protocols.Low expression of basic fibroblastic growth factor in mesenchymal stem cells and bone marrow of children with aplastic anemia.Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment

P2860

Q33604344-97AAC93C-5A5C-4D1A-8310-570D3CAADE7C Q34360341-F6F73A13-0B10-4189-B2E2-E03FD47C4968 Q34778145-88729841-C1D2-4DCF-B084-7EFA50A239BC Q34986999-6DFC36ED-FFE1-4C87-A6B4-B75CC0C26144 Q34989207-3515947F-BA8D-4E72-979A-4F970C823CC6 Q35568527-32E00FC2-4309-4F0E-9EA0-476045693789 Q35930597-861CFA0D-3B44-41C2-BF3D-06E32F31BDF2 Q35938808-C0734D05-58F6-4200-87B4-94669CFD170C Q36167878-1659937E-422C-477B-8499-9CC9294F9CDE Q36980277-64188FF8-3A36-4E8E-97E4-615299644D57 Q37040881-0227CD8D-1D08-491A-A846-6097CD444A94 Q37584833-73CD9AE2-12B0-4478-A632-1DC797E8B358 Q37672830-9916B008-AD38-4EB2-B622-D59A5542A78E Q38949394-B72C0B91-5189-4E0D-AADC-F7F9944FA60E Q39906238-E4D8D767-D661-4314-8BB5-69E8CA10A318 Q40298403-317A5CBD-65BC-4BF1-A350-59FAC983EBEE Q41189329-D586EF2A-18C0-427D-926C-D231B88F7A84 Q41450639-1719D4B6-3BF8-4182-B9F3-7354E04F6711 Q44800086-7F30D62A-92EB-427C-99B1-AE9A24D8BEB1 Q46984091-17F3111B-8A71-4C38-B596-45B8BD88FDE6 Q47834340-0900BC03-72FA-4E09-A340-71CC3DD65B8C Q51525728-F8C87BEB-8960-4D77-9554-2BF549B447F1 Q58782280-153C5FCD-D622-4A89-852D-C583F6D29CBA

P2860

Bone marrow graft in man after conditioning by antilymphocytic serum.

http://www.wikidata.org/entity/Q50417610

description

1970 nî lūn-bûn

@nan

1970年の論文

@ja

1970年学术文章

@wuu

1970年学术文章

@zh

1970年学术文章

@zh-cn

1970年学术文章

@zh-hans

1970年学术文章

@zh-my

1970年学术文章

@zh-sg

1970年學術文章

@yue

1970年學術文章

@zh-hant

name

Bone marrow graft in man after conditioning by antilymphocytic serum.

@en

Bone marrow graft in man after conditioning by antilymphocytic serum.

@nl

type

label

Bone marrow graft in man after conditioning by antilymphocytic serum.

@en

Bone marrow graft in man after conditioning by antilymphocytic serum.

@nl

prefLabel

Bone marrow graft in man after conditioning by antilymphocytic serum.

@en

Bone marrow graft in man after conditioning by antilymphocytic serum.

@nl

P1433

Q50417610-76A4F83D-FAC0-4A4F-9482-B79EF948C2E6

P1476

Q50417610-11C6F5A0-D07F-4442-A2DB-BA011DDD4FF1

P2093

Q50417610-14A425C6-2B52-4A46-B0A3-E0066301F2A5

Q50417610-492C9E80-1BED-4A90-AE99-0207FF36E344

Q50417610-6728427C-1C09-4E88-AD75-218A5A5B1D4B

Q50417610-757B1E22-3B19-4588-9E86-1AFF148701FB

Q50417610-A134638B-17E4-4FA8-B118-8DBC4403ECCE

Q50417610-BAE708F8-1FBD-4CDA-970F-ECC2A587518D

Q50417610-D1843B7C-F9DF-4755-9603-2E690C72A602

Q50417610-E1F815B4-0B78-4FF7-9C65-E0AB792A9D6F

Q50417610-F83926C9-35E8-42FD-BA6A-6FB2B8FA4586

P2860

Q50417610-189348B8-BB5E-414C-B53A-9E827ABFFAC4

Q50417610-38415967-7565-4ECF-966E-945AC38747B0

P304

Q50417610-B3891C13-317F-4013-BCA2-CF2B3976E96B

P31

Q50417610-1D007144-B57A-4311-904E-636C914C99EB

P356

Q50417610-BF93223B-E55A-45FA-9741-654755884D82

P407

Q50417610-E8E051C0-6EB3-4FFE-8C7A-4AA9BC0541D5

P433

Q50417610-F82A79F1-D227-423D-B9F9-A51D03C76E40

P478

Q50417610-BCBFD5A4-7BD9-4B88-A8ED-766B5F815BD3

P577

Q50417610-DF3A24A3-F047-42F0-8FE7-5C2CFD96BFF0

P5875

Q50417610-3DD381A8-EB4D-4962-9733-3CE59E4FF63F

P698

Q50417610-0EF0983F-B9F8-4E42-B6FA-46C5C95BABFF

P932

Q50417610-ABE02991-04C7-4D8B-8DA7-36D249778339

P356

P1433

P1476

Bone marrow graft in man after conditioning by antilymphocytic serum.

@en

P2093

Amiel JL

http://www.w3.org/2001/XMLSchema#string

Choay J

http://www.w3.org/2001/XMLSchema#string

Hayat M

http://www.w3.org/2001/XMLSchema#string

Jasmin C

http://www.w3.org/2001/XMLSchema#string

Mathé G

http://www.w3.org/2001/XMLSchema#string

Schlumberger JR

http://www.w3.org/2001/XMLSchema#string

Schneider M

http://www.w3.org/2001/XMLSchema#string

Schwarzenberg L

http://www.w3.org/2001/XMLSchema#string

Trolard P

http://www.w3.org/2001/XMLSchema#string

P2860

HAEMATOPOIETIC CHIMERA IN MAN AFTER ALLOGENIC (HOMOLOGOUS) BONE-MARROW TRANSPLANTATION. (CONTROL OF THE SECONDARY SYNDROME. SPECIFIC TOLERANCE DUE TO THE CHIMERISM).

Transplantation of allogeneic haemopoietic tissue in adult anaemic mice of the W series using antilymphocytic serum.

P304

131-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJ.2.5702.131

http://www.w3.org/2001/XMLSchema#string

P407

P433

5702

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

1970-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

18260151

http://www.w3.org/2001/XMLSchema#string

P698

4909449

http://www.w3.org/2001/XMLSchema#string

P932

1699952

http://www.w3.org/2001/XMLSchema#string